Focused on diabetes care products, the company develops and sells insulin delivery devices such as pen needles, syringes, and related accessories used by people with diabetes. It was spun off from Becton, Dickinson and Company in 2022, giving it a pure‑play focus on the global insulin injection mark...
1 member of Congress has disclosed 2 trades in Embecta Corp. (EMBC), a Healthcare company. The buy/sell breakdown shows 0 purchases versus 2 sales, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2020-07-10 | Ted S. Yoho | sell | $567+ |
| 2020-07-10 | Ted S. Yoho | sell | $2K+ |